AstraZeneca has been granted protection from future product liability claims related to its Covid-19 vaccine hopeful by most of the countries with which it has struck supply agreements. With 25 companies testing their vaccine candidates on humans, the question of who pays for any claims for damages in case of side effects has been a tricky point in supply ne […]

Read More on Times of India